Oath Planning »

Tg Therapeutics shares owned by Oath Planning

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Oath Planning from 13F filings

Historical chart of Oath Planning investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Oath Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Oath Planning

Quarter filed Position value Share count Share price at filing
2026-06-30 $275k 5.0k 54.94

More positions owned by Oath Planning

Vanguard Bd Index Fds Short Trm Bond (BSV)
Victory Portfolios Ii Core Bd Etf (UITB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Schwab Strategic Tr Fundamental Intl (FNDF)
Ea Series Trust Freedom 100 Em (FRDM)
Vanguard Index Fds Value Etf (VTV)
PNC Financial Services (PNC)
Dbx Etf Tr Xtrack Msci Eafe (DBEF)
Ea Series Trust Brid Omn Sma Etf (BSVO)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
HEICO Corporation (HEI)
Select Sector Spdr Tr St Str Real Etf (XLRE)

View all positions for Oath Planning

Top funds holding Tg Therapeutics

BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Geode Capital Management
ClearBridge Advisors
Jane Street
Goldman Sachs Group
Soleus Capital Management
Congress Asset Management
Citadel Advisors
Susquehanna International
Pictet Asset Management Holding SA
Hood River Capital Management
Two Sigma Investments

View all funds holding Tg Therapeutics